Repligen Corp (NASDAQ: RGEN) stock enjoyed a major increase of 10.1% on 7/16/24. The shares closed at $135.00. Trading volume in this advance was normal. The stock has been weak relative to the market over the last nine months but has risen 12.7% during the last week.
Current PriceTarget Research Rating
RGEN is expected to continue to be a modest Value Builder reflecting capital returns that are forecasted to exceed the cost of capital.
Repligen has a current Value Trend Rating of F (Lowest Rating). This rating combines highly consistent signals from two proprietary PTR measures of a stock’s attractiveness. Repligen has a poor Appreciation Score of 21 and a poor Power Rating of 17, resulting in the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment